Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A metabolomic signatures in hyperuricemia: a systematic review.

Metabolomics : Official journal of the Metabolomic Society·2026

Same author

The association between pan-immune-inflammation value and diabetic kidney disease: a combined cross-sectional and prospective cohort study.

BMC endocrine disorders·2026

Same author

Endometriosis is Widely Involved in Retroperitoneal Lymph Nodes: Rare Systemic Disseminated Manifestations.

Journal of minimally invasive gynecology·2026

Same author

Effects of different processing methods on bioaccessibility of phenolic compounds in flaxseed meal.

Food chemistry·2026

Same author

Exploring the dosage-effect relationship and mechanism of Huangqi in Huangqi Guizhi Wuwu decoction for treating rheumatoid arthritis based on the compatibility of the formula.

Journal of ethnopharmacology·2026

Same author

Integrating Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation to Elucidate the Efficacy and Mechanism of Wanbi Hantong Yin in Rheumatoid Arthritis.

Combinatorial chemistry & high throughput screening·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Increasing vaccine potency through exosome antigen targeting.

Zachary C Hartman¹, Junping Wei, Oliver K Glass

¹Duke Comprehensive Cancer Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

|October 18, 2011

Summary

Targeting tumor antigens to exosomes enhances immune responses and anti-tumor effects. This exosome targeting strategy shows promise for improving cancer vaccines and potentially other vaccines.

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8⁺ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Related Experiment Videos

Last Updated: May 28, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8⁺ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Area of Science:

Immunology
Oncology
Biotechnology

Background:

Classical cancer vaccine approaches targeting tumor-associated antigens (TAAs) have shown limited efficacy.
Exosomes are known to traffic to antigen-presenting cells (APCs), suggesting potential for enhanced immunogenicity.
A method exists to target proteins to exosomes using the C1C2 domain of lactadherin.

Purpose of the Study:

To investigate if targeting TAAs to exosomes can increase their immunogenicity.
To evaluate the therapeutic anti-tumor effects of exosome-targeted TAAs.

Main Methods:

Adenoviral vectors were engineered to express the extracellular domain (ECD) of carcinoembryonic antigen (CEA) and HER2, fused to the C1C2 lactadherin domain.
Expression of C1C2 fusion proteins in exosomes was analyzed in vitro.
Antigen-specific immune responses and therapeutic anti-tumor effects were assessed in transgenic animal models.

Main Results:

C1C2 fusion proteins demonstrated enhanced expression in exosomes.
Significant improvements in antigen-specific immune responses were observed in both naïve and tolerant animal models.
Markedly enhanced therapeutic anti-tumor effects were achieved in a HER2+ transgenic animal model.

Conclusions:

Exosomal targeting of TAAs can significantly enhance immunogenicity and anti-tumor efficacy.
The mode of protein secretion and trafficking influences TAA immunogenicity, potentially explaining the ineffectiveness of non-mutated TAAs in cancer vaccines.
Exosome targeting represents a promising strategy for future anti-cancer vaccination protocols and may be applicable to other vaccine development challenges.